Miach

Miach Orthopaedics Appoints Arjun Ishwar Vice President of Sales & Marketing

Retrieved on: 
Tuesday, October 11, 2022
Health, Surgery, Physical Therapy, Medical Devices, Adoption, LinkedIn, Biomedical engineering, National Football League Players Association, Leg, Use, Purdue University, Hospital, Bridge, Tibia, Anatomy, National, ACL, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Tears, Patient, Research, Twitter, Instagram, Regeneration, Anterior cruciate ligament, NFL, Implant, MRI, Rupture, Technology, BEAR, De novo, Food, Knee, Boston, Marketing, Femur, Merck KGaA v. Integra Lifesciences I, Ltd., Tissue engineering, Blood, Association, CEO, Trauma, Orthopedic surgery, ACell, Regenerative medicine, Bachelor, Ishvara, Leadership, Dentistry, Medical device, Science, Facebook, Miach

Miach Orthopaedics , Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR) Implant, today announced Arjun Ishwar has joined the company as vice president of sales and marketing.

Key Points: 
  • Miach Orthopaedics , Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR) Implant, today announced Arjun Ishwar has joined the company as vice president of sales and marketing.
  • Ishwar brings extensive experience in corporate strategic planning and execution, sales and marketing leadership, and commercialization combined with a technical background in tissue engineering and regenerative medicine.
  • Lending his expertise to the BEAR Implant is a natural fit, said Patrick McBrayer, president and CEO, Miach Orthopaedics.
  • For more information on Miach Orthopaedics and its products, visit www.miachortho.com and follow the company on Facebook , Instagram , Twitter and LinkedIn .

Miach Orthopaedics Appoints Patrick McBrayer President & CEO

Retrieved on: 
Wednesday, September 7, 2022
Biotechnology, Surgery, Medical Devices, Health, Physical Therapy, National, Femur, CEO, Technology, Rupture, Spine, Research, McBrayer, Regulation of tobacco by the U.S. Food and Drug Administration, BEAR, Tibia, Army of the United States, Regenerative medicine, Thomas Edison, Boston, Leg, Implant, Blood, Â, Food, ACell, LinkedIn, De novo, ACL, Bridge, Patient, Instagram, Leadership, Use, National Football League Players Association, Hospital, Biotechnology, Twitter, MRI, Johnson & Johnson, Association, Infantry, NFL, Orthopedic surgery, United States service academies, Exogen, Dentistry, Management, Medical device, Miach, Facebook, Insming

Miach Orthopaedics, Inc. , a company transforming the treatment of anterior cruciate ligament tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR) Implant, today announced healthcare industry veteran Patrick McBrayer has been appointed president and chief executive officer.

Key Points: 
  • Miach Orthopaedics, Inc. , a company transforming the treatment of anterior cruciate ligament tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR) Implant, today announced healthcare industry veteran Patrick McBrayer has been appointed president and chief executive officer.
  • The team at Miach Orthopaedics has made tremendous progress over the last year in driving market adoption of the BEAR Implant for ACL restoration, said Patrick McBrayer, president and CEO, Miach Orthopaedics.
  • McBrayer replaces Christopher Joyce, who served as interim president and CEO since Martha Shadan left the company in June.
  • Prior to joining Miach, McBrayer served as president and CEO of ACell, AxioMed Spine Corporation, Exogen and Osteotech; CEO of Xylos Corporation; and co-founder of Transave (now Insmed).

Seminal Research for Miach Orthopaedics’ BEAR® Implant Wins OREF Award

Retrieved on: 
Monday, February 7, 2022
Science, Biotechnology, Research, Physical Therapy, Surgery, Health, Medical Devices, Other Health, The Foundation for Young Australians, Miach, NFL, Orthopedic surgery, Use, Boston, Kappa Delta, Bridge, Philippine Orthopedic Center, Harvard Medical School, Connective tissue, Research, National, Twitter, Rupture, Association, BEAR, Femur, Boston Children's Hospital, FDA, Technology, Patient, National Football League Players Association, Blood, Tibia, CEO, Hospital, ACL, De novo, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Lists of diseases, Leg, Food, LinkedIn, Implant, MRI, Medical device, Dentistry, Facebook, The BEAR® Implant, Miach Orthopaedics, Inc., THE BEAR® IMPLANT, MIACH ORTHOPAEDICS, INC.

Miach Orthopaedics , Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue restoration, today announced Miach founder Dr. Martha Murrays research on the development of the companys BEAR Implant was selected for the 2022 Orthopaedic Research and Education Foundation (OREF) Clinical Research Award.

Key Points: 
  • Miach Orthopaedics , Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue restoration, today announced Miach founder Dr. Martha Murrays research on the development of the companys BEAR Implant was selected for the 2022 Orthopaedic Research and Education Foundation (OREF) Clinical Research Award.
  • Research and development of the BEAR Implant has been Dr. Murrays lifes work, and it is exciting to see it recognized by OREF, said Martha Shadan, president and CEO, Miach Orthopaedics.
  • The BEAR Implant is the first medical technology to clinically demonstrate that it enables healing of a patient's torn anterior cruciate ligament (ACL).
  • The Bridge-Enhanced ACL Restoration (BEAR) Implant is a proprietary bio-engineered implant used to facilitate healing of the torn ACL.

Miach Orthopaedics Names New CFO, Company Director

Retrieved on: 
Monday, September 27, 2021
Health, Surgery, Physical Therapy, Medical Devices, Blood, ACL, Food, Leg, Trauma, Elective surgery, Sports medicine, MRI, National Football League Players Association, National, Seedo, Patient, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Hospital, Tibia, Connective tissue, Femur, Association, Babson College, Orthopedic surgery, LinkedIn, Medicine, NFL, Twitter, CEO, University, Virginia University, West Virginia University, Polymer, Implant, University of Massachusetts, Rupture, Technology, Research, CFO, Bridge, De novo, Miach, Spine, NYSE, BEAR, Boston, Management, Medical device, Dentistry, the BEAR® Implant, Miach Orthopaedics, Inc., THE BEAR® IMPLANT, MIACH ORTHOPAEDICS, INC.

Both Chris and Kevin bring expertise that will benefit Miach during this pivotal period of company growth.

Key Points: 
  • Both Chris and Kevin bring expertise that will benefit Miach during this pivotal period of company growth.
  • Miach is launching the Bridge-Enhanced ACL Restoration (BEAR) Implant commercially in the U.S. this fall.
  • Miach Orthopaedics , Inc. is a privately held company located in Westborough, Massachusetts, dedicated to developing bio-engineered surgical implants for connective tissue restoration.
  • For more information on Miach Orthopaedics and its products, visit www.miachortho.com and follow the company on Facebook , Twitter and LinkedIn .

Miach Orthopaedics Names Stephen Wohlert, PhD, Vice President of Manufacturing

Retrieved on: 
Tuesday, January 21, 2020
Medical devices, Surgery, Hospitals, Engineering, Manufacturing, Other Health, Biotechnology, Physical therapy, General Health, Health, Prosthetics, Miach, Tuatha Dé Danann, Implant, Medicine, Branches of biology, Health, ACL Injuries and the BEAR® Implant, Miach Orthopaedics, Inc.

Miach Orthopaedics, Inc. , a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, today announced that Stephen Wohlert, PhD, has joined the company as vice president of manufacturing.

Key Points: 
  • Miach Orthopaedics, Inc. , a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, today announced that Stephen Wohlert, PhD, has joined the company as vice president of manufacturing.
  • Stephen is an experienced leader with a successful track record of transferring concepts to product development and commercialization, said Martha Shadan, president and CEO, Miach Orthopaedics.
  • Miach Orthopaedics , Inc. is a privately held company located in Westborough, Massachusetts, dedicated to developing bio-engineered surgical implants for connective tissue repair.
  • For more information on Miach Orthopaedics and its products, visit www.miachortho.com and follow the company on Twitter and LinkedIn .

Miach Orthopaedics Names Michael J. McNulty Vice President of Sales and Marketing

Retrieved on: 
Tuesday, October 15, 2019
Medical Supplies, Medical devices, Health, Surgery, Other Health, Clinical trials, McNulty, Naval War College, United States Merchant Marine Academy, Sales management, Miach, Business, Articles, ACL Injuries and the BEAR® Implant, Miach Orthopaedics, Inc.

Miach Orthopaedics , Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, today announced that Michael J. McNulty has joined the company as vice president of sales and marketing.

Key Points: 
  • Miach Orthopaedics , Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, today announced that Michael J. McNulty has joined the company as vice president of sales and marketing.
  • Mike is a talented commercial leader who is skilled at hiring, developing and motivating his team to consistently deliver exceptional sales performance, said Martha Shadan, president and CEO, Miach Orthopaedics.
  • Most recently, McNulty served as senior director of sales in the Biologics Division at Smith & Nephew following the companys acquisition of Rotation Medical, where he served as vice president of sales and marketing.
  • Previously, McNulty served as vice president of sales for Arstasis, where he was responsible for market development, commercial launch, sales training and sales management.

Miach Orthopaedics Expands Senior Executive Team

Retrieved on: 
Wednesday, April 17, 2019
Surgery, Health, Biotechnology, Clinical trials, Medical Supplies, Medicine, Medical specialties, Knee ligaments, Prosthetics, Branches of biology, Ligament, Skeletal system, Soft tissue, Miach, Orthopedic surgery, Anterior cruciate ligament reconstruction, Anterior cruciate ligament

Miach Orthopaedics , Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, today announced two additions to its senior executive team to oversee quality systems and clinical trials for the Bridge-Enhanced ACL Repair (BEAR) implant for anterior cruciate ligament (ACL) repair.

Key Points: 
  • Miach Orthopaedics , Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, today announced two additions to its senior executive team to oversee quality systems and clinical trials for the Bridge-Enhanced ACL Repair (BEAR) implant for anterior cruciate ligament (ACL) repair.
  • We are building a team of hard-working, collaborative, innovative employees at Miach, said Martha Shadan, president and CEO.
  • Miach Orthopaedics , Inc. is a privately held company located in Westborough, Massachusetts, dedicated to developing bio-engineered surgical implants for connective tissue repair.
  • For more information on Miach Orthopaedics and its products, visit www.miachortho.com and follow the company on Twitter and LinkedIn .